A guide to treating gait impairment with prolonged-release fampridine (Fampyra®) in patients with multiple sclerosis | Neurología (English Edition)
EU investigating Teva for blocking rivals to multiple sclerosis drug | Reuters
Teva Pursues Regulatory Approval in Japan for MS Drug Copaxone
Laquinimod, an Oral Product in Development for the Treatment of Relapsing Remitting Multiple Sclerosis Steve Glenski, PharmD Medical Affairs Teva Neuroscience. - ppt download
FDA approves first generic version of epilepsy drug Sabril from Teva
Advances in oral immunomodulating therapies in relapsing multiple sclerosis - The Lancet Neurology
Effect of generic glatiramer acetate on spending and use of drugs for multiple sclerosis | Neurology
![Teva Canada Announces the Launch of a Bioequivalent Generic Version of [Pr]Gilenya®, [Pr]Teva-Fingolimod Capsules for the treatment of Relapsing-Remitting Multiple Sclerosis (MS)](https://mma.prnewswire.com/media/1019389/Teva_Canada_Limited_Teva_Canada_Announces_the_Launch_of_a_Bioequ.jpg?p=facebook "Teva Canada Announces the Launch of a Bioequivalent Generic Version of [Pr]Gilenya®, [Pr]Teva-Fingolimod Capsules for the treatment of Relapsing-Remitting Multiple Sclerosis (MS)")
Teva Canada Announces the Launch of a Bioequivalent Generic Version of [Pr]Gilenya®, [Pr]Teva-Fingolimod Capsules for the treatment of Relapsing-Remitting Multiple Sclerosis (MS)
EC Investigating Teva for Competing MS Drug
Teriflunomide in multiple sclerosis: an update | Neurodegenerative Disease Management
New Oral Agents for Multiple Sclerosis: A Healthcare Professional's Guide
PDF) Placebo-Controlled Trial of Oral Laquinimod for Multiple Sclerosis for the ALLEGRO Study Group
In blow to Teva, UK court rules in favor of Copaxone patent challenge | The Times of Israel
Generic Version Of Pricey MS Treatment Didn't Reduce Drug Costs Much For Patients : Shots - Health News : NPR
Pioglitazone Could Play a Role in MS Treatment | Everyday Health
MS Minute: Oral Therapies for MS - Practical Neurology
Teva Pays $925,000 to Settle Mississippi Drug-Price Case, Seek More Pacts - Bloomberg
Europe Multiple Sclerosis Drugs Market 2020-2027
Teva faces EU antitrust probe over MS drug Copaxone -
5 Drug Stocks In Focus On World MS Day | Investing.com
EC Investigating Teva for Competing MS Drug
TEVA 2908 Pill (White/Round/6mm) - Pill Identifier - Drugs.com
Covid-19 Update: Multiple Sclerosis Treatment Market Industry Size & Share, Swot Analysis (2019-2026) | Teva Pharmaceuticals Industries Ltd., Bayer AG, Biogen Inc – Data Bridge Market Research
Two decades of glatiramer acetate: From initial discovery to the current development of generics - Journal of the Neurological Sciences
